NRIX compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name

NRIXNurix Therapeutics, Inc.

Mkt capRevenueRevenue

IMTXImmatics N.V.

Mkt capRevenueRevenue

Compare

NRIXNurix Therapeutics, Inc.

IMTXImmatics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NRIX 7

GILDGilead Sciences, Inc. (Gilead)customer

PFEPfizer Inc. (Pfizer)customer

SNYSanofi S.A. (Sanofi)customer

SNYNFSanoficustomer

3 more · NRIX chain ›

Shared 0

No shared counterparties.

Only IMTX 2

BMYBristol-Myers Squibbcustomer

MRNAModernaTXcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

NRIX, solidIMTX, dashed

NRIXNurix Therapeutics, Inc.

25.68· pre 25.45· delayed

Mkt cap$2.8BRevenue$673MQ3 FY26Revenue$84MFY25

IMTXImmatics N.V.

7.05· pre 7.05· delayed

Pre-marketNov 3 '26delayed

Mkt cap$965.3MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

NRIXNurix Therapeutics, Inc.

IMTXImmatics N.V.

25.68pre 25.45delayed

Price

7.05pre 7.05delayed

$2.8B

Mkt cap

$965.3M

Q3 FY26$673M

Revenue

—

FY25$84M

Revenue

—

NRIX25.68vsIMTX7.05Pre-marketNov 3 '26delayed